These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2400911)

  • 1. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease.
    Tooyama I; Kimura H; Akiyama H; McGeer PL
    Brain Res; 1990 Jul; 523(2):273-80. PubMed ID: 2400911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histocompatibility profile of selected Latin American countries.
    Santiago-Delpín EA
    Transplant Proc; 1991 Apr; 23(2):1861-4. PubMed ID: 2053180
    [No Abstract]   [Full Text] [Related]  

  • 3. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.
    McGeer PL; Itagaki S; Tago H; McGeer EG
    Neurosci Lett; 1987 Aug; 79(1-2):195-200. PubMed ID: 3670729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA in Singapore Chinese with rheumatoid arthritis.
    Boey ML; Wee GB; Mohan C; Howe HS; Chan SH; Feng PH
    J Rheumatol; 1992 Oct; 19(10):1517-9. PubMed ID: 1464861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinating conditions.
    van der Maesen K; Hinojoza JR; Sobel RA
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):346-58. PubMed ID: 10218630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
    Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
    Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain.
    Styren SD; Civin WH; Rogers J
    Exp Neurol; 1990 Oct; 110(1):93-104. PubMed ID: 1698655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens.
    Steinhoff G; Wonigeit K; Schäfers HJ; Haverich A
    J Heart Transplant; 1989; 8(5):360-70. PubMed ID: 2552061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue.
    Itagaki S; McGeer PL; Akiyama H
    Neurosci Lett; 1988 Sep; 91(3):259-64. PubMed ID: 2972943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
    Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
    Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex antigen expression on rat microglia following epidural kainic acid lesions.
    Akiyama H; Itagaki S; McGeer PL
    J Neurosci Res; 1988; 20(2):147-57. PubMed ID: 3172275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune system associated antigens expressed by cells of the human central nervous system.
    Luber-Narod J; Rogers J
    Neurosci Lett; 1988 Nov; 94(1-2):17-22. PubMed ID: 3266526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class II-positive microglia in human brain: association with Alzheimer lesions.
    Perlmutter LS; Scott SA; Barrón E; Chui HC
    J Neurosci Res; 1992 Dec; 33(4):549-58. PubMed ID: 1484388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune system response in Alzheimer's disease.
    McGeer PL; Akiyama H; Itagaki S; McGeer EG
    Can J Neurol Sci; 1989 Nov; 16(4 Suppl):516-27. PubMed ID: 2804814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia in the rat neurohypophysis increase expression of class I major histocompatibility antigens following central nervous system injury.
    Moffett CW; Paden CM
    J Neuroimmunol; 1994 Mar; 50(2):139-51. PubMed ID: 8120135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modulation of the expression of histocompatibility antigens class I (HLA-A,B,C) in the human pancreas].
    Leprini A; Valente U; Barocci S; Fontana I; Angelini G; Bottero S; Ballerini A; Nocera A
    Boll Soc Ital Biol Sper; 1989 Mar; 65(3):187-94. PubMed ID: 2569881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors.
    Mattiace LA; Davies P; Dickson DW
    Am J Pathol; 1990 May; 136(5):1101-14. PubMed ID: 1693471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia in the immune surveillance of the brain: human microglia constitutively express HLA-DR molecules.
    Gehrmann J; Banati RB; Kreutzberg GW
    J Neuroimmunol; 1993; 48(2):189-98. PubMed ID: 8227316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
    Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S
    Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.